Chronic Lymphocytic Leukemia / / edited by Pablo Oppezzo.
B-cell chronic lymphocytic leukemia (CLL) is considered a single disease with extremely variable course, and survival rates ranging from months to decades. It is clear that clinical heterogeneity reflects biologic diversity with at least two major subtypes in terms of cellular proliferation, clinica...
Saved in:
| TeilnehmendeR: | |
|---|---|
| Place / Publishing House: | [Place of publication not identified] : : InTech,, 2012. |
| Year of Publication: | 2012 |
| Language: | English |
| Physical Description: | 1 online resource (464 pages) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| id |
993547038104498 |
|---|---|
| ctrlnum |
(CKB)3230000000075769 (NjHacI)993230000000075769 (oapen)https://directory.doabooks.org/handle/20.500.12854/65547 (EXLCZ)993230000000075769 |
| collection |
bib_alma |
| record_format |
marc |
| spelling |
Oppezzo, Pablo edt Chronic Lymphocytic Leukemia / edited by Pablo Oppezzo. IntechOpen 2012 [Place of publication not identified] : InTech, 2012. 1 online resource (464 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Description based on: online resource; title from PDF information screen (InTech, viewed October 21, 2022). Includes bibliographical references and index. B-cell chronic lymphocytic leukemia (CLL) is considered a single disease with extremely variable course, and survival rates ranging from months to decades. It is clear that clinical heterogeneity reflects biologic diversity with at least two major subtypes in terms of cellular proliferation, clinical aggressiveness and prognosis. As CLL progresses, abnormal hematopoiesis results in pancitopenia and decreased immunoglobulin production, followed by nonspecific symptoms such as fatigue or malaise. A cure is usually not possible, and delayed treatment (until symptoms develop) is aimed at lengthening life and decreasing symptoms. Researchers are playing a lead role in investigating CLL's cause and the role of genetics in the pathogenesis of this disorder. Research programs are dedicated towards understanding the basic mechanisms underlying CLL with the hope of improving treatment options. English Chronic lymphocytic leukemia. Musculoskeletal medicine 953-307-881-2 Oppezzo, Pablo, editor. |
| language |
English |
| format |
eBook |
| author2 |
Oppezzo, Pablo, |
| author_facet |
Oppezzo, Pablo, |
| author2_variant |
p o po p o po |
| author2_role |
TeilnehmendeR |
| title |
Chronic Lymphocytic Leukemia / |
| spellingShingle |
Chronic Lymphocytic Leukemia / |
| title_full |
Chronic Lymphocytic Leukemia / edited by Pablo Oppezzo. |
| title_fullStr |
Chronic Lymphocytic Leukemia / edited by Pablo Oppezzo. |
| title_full_unstemmed |
Chronic Lymphocytic Leukemia / edited by Pablo Oppezzo. |
| title_auth |
Chronic Lymphocytic Leukemia / |
| title_new |
Chronic Lymphocytic Leukemia / |
| title_sort |
chronic lymphocytic leukemia / |
| publisher |
IntechOpen InTech, |
| publishDate |
2012 |
| physical |
1 online resource (464 pages) |
| isbn |
953-51-6746-4 953-307-881-2 |
| callnumber-first |
R - Medicine |
| callnumber-subject |
RC - Internal Medicine |
| callnumber-label |
RC643 |
| callnumber-sort |
RC 3643 C476 42012 |
| illustrated |
Not Illustrated |
| dewey-hundreds |
600 - Technology |
| dewey-tens |
610 - Medicine & health |
| dewey-ones |
616 - Diseases |
| dewey-full |
616.99419 |
| dewey-sort |
3616.99419 |
| dewey-raw |
616.99419 |
| dewey-search |
616.99419 |
| work_keys_str_mv |
AT oppezzopablo chroniclymphocyticleukemia |
| status_str |
n |
| ids_txt_mv |
(CKB)3230000000075769 (NjHacI)993230000000075769 (oapen)https://directory.doabooks.org/handle/20.500.12854/65547 (EXLCZ)993230000000075769 |
| carrierType_str_mv |
cr |
| is_hierarchy_title |
Chronic Lymphocytic Leukemia / |
| author2_original_writing_str_mv |
noLinkedField |
| _version_ |
1796648796336160769 |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01008nam a2200289 i 4500</leader><controlfield tag="001">993547038104498</controlfield><controlfield tag="005">20221021202854.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">221021s2012 xx ob 001 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">953-51-6746-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)3230000000075769</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)993230000000075769</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/65547</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)993230000000075769</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC643</subfield><subfield code="b">.C476 2012</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.99419</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Oppezzo, Pablo</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Chronic Lymphocytic Leukemia /</subfield><subfield code="c">edited by Pablo Oppezzo.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">IntechOpen</subfield><subfield code="c">2012</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">[Place of publication not identified] :</subfield><subfield code="b">InTech,</subfield><subfield code="c">2012.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (464 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on: online resource; title from PDF information screen (InTech, viewed October 21, 2022).</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">B-cell chronic lymphocytic leukemia (CLL) is considered a single disease with extremely variable course, and survival rates ranging from months to decades. It is clear that clinical heterogeneity reflects biologic diversity with at least two major subtypes in terms of cellular proliferation, clinical aggressiveness and prognosis. As CLL progresses, abnormal hematopoiesis results in pancitopenia and decreased immunoglobulin production, followed by nonspecific symptoms such as fatigue or malaise. A cure is usually not possible, and delayed treatment (until symptoms develop) is aimed at lengthening life and decreasing symptoms. Researchers are playing a lead role in investigating CLL's cause and the role of genetics in the pathogenesis of this disorder. Research programs are dedicated towards understanding the basic mechanisms underlying CLL with the hope of improving treatment options.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Chronic lymphocytic leukemia.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Musculoskeletal medicine</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">953-307-881-2</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Oppezzo, Pablo,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-02-22 20:39:00 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2012-12-09 08:17:33 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338484040004498&Force_direct=true</subfield><subfield code="Z">5338484040004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338484040004498</subfield></datafield></record></collection> |